CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

N-Terminal peptide of proopiomelanocortin

protein in Homo sapiens

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionApr 18, 2020
Entity authorityQ6951408 ↗
Source-derived summary

The N-terminal peptide/fragment of proopiomelanocortin (NPP; N-POMC), also known as pro-γ-MSH, is a naturally occurring, endogenous metabolite of the polypeptide proopiomelanocortin (POMC).

N-POMC is also a precursor for γ1-MSH, γ2-MSH, and γ3-MSH, and can form them through proteolytic cleavage.

N-POMC is an adrenal growth factor.

Editorial summary

The public source identifies “N-Terminal peptide of proopiomelanocortin” as protein in Homo sapiens. This brief keeps that definition visible, then builds a research path around N-Terminal, peptide and proopiomelanocortin.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current 45-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with N-Terminal, peptide and proopiomelanocortin providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “N-Terminal peptide of proopiomelanocortin”, the useful work is to connect “protein in Homo sapiens” to the records capable of establishing context and consequence.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Apr 18, 2020. The linked authority identifier is Q6951408.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “N-Terminal peptide of proopiomelanocortin”, its source revision and the description used here.
  2. Expand the search: follow N-Terminal peptide of proopiomelanocortin primary sources, N-Terminal peptide of proopiomelanocortin archive and N-Terminal research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “N-Terminal peptide of proopiomelanocortin”?
  2. Which institution is responsible for the underlying evidence?
  3. What terminology or title could unlock a more precise catalogue search?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “N-Terminal peptide of proopiomelanocortin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.